Povidone Iodine Nasal Application to Prevent Intraoperative Spread of SARS-CoV-2
Status:
Not yet recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The primary aim is to test whether preoperative asepsis with 5% nasal povidone iodine versus
no preoperative asepsis with 5% nasal povidone iodine reduces proximal and distal SARS-CoV-2
transmission in operating rooms among patients who are acutely infected with SARS-CoV-2. The
secondary aim is to test viral infectivity.